ArticleNeuro-oncology2025

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Anna Laemmerer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.